Literature DB >> 3219307

Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis.

A Cavalleri1, F Gobba, L Bacchella, F Luberto, A Ziccardi.   

Abstract

Serum type III procollagen peptide (PIIIP) concentrations were determined in 36 male workers exposed to asbestos fibres in the production of asbestos cement items and in 13 healthy male controls. Mean (SD) PIIIP serum concentrations were 9.3 (1.5) ng/ml (range 7-12) in the controls and 13.7 (3.5)ng/ml (range 7.5-20) in the asbestos workers; the difference was statistically significant (p less than 0.01). The exposed workers were subdivided according to presence or absence of radiological signs of asbestosis and intensity and duration of exposure. PIIIP serum values of workers with asbestos related interstitial fibrosis were the highest of the groups at 14.6 (2.3) ng/ml. In workers with heavy exposure the PIIIP values were significantly related to duration of exposure (r = 0.95; p less than 0.01). PIIIP serum values may be a useful index for the early diagnosis of asbestos induced pulmonary fibrosis and its use should be considered as part of the biological monitoring of exposed workers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219307      PMCID: PMC1009702          DOI: 10.1136/oem.45.12.818

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  29 in total

Review 1.  Biosynthesis of procollagen.

Authors:  J H Fessler; L I Fessler
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

2.  Lung function in chrysotile asbestos mine and mill workers of Quebec.

Authors:  M R Becklake; G Fournier-Massey; C E Rossiter; J C McDonald
Journal:  Arch Environ Health       Date:  1972-06

3.  Diagnosis of "asbestosis". Observations from a longitudinal survey of shipyard pipe coverers.

Authors:  R L Murphy; E A Gaensler; B G Ferris; M Fitzgerald; N Solliday; W Morrisey
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

4.  Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis.

Authors:  J A Madri; H Furthmayr
Journal:  Hum Pathol       Date:  1980-07       Impact factor: 3.466

5.  Average normal values for the forced expiratory volume in white Caucasian males.

Authors:  J E Cotes; C E Rossiter; I T Higgins; J C Gilson
Journal:  Br Med J       Date:  1966-04-23

6.  Collagen polymorphism in idiopathic chronic pulmonary fibrosis.

Authors:  J M Seyer; E T Hutcheson; A H Kang
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

7.  Radioimmunoassay for type III procollagen peptide and its application to human liver disease.

Authors:  H Rohde; L Vargas; E Hahn; H Kalbfleisch; M Bruguera; R Timpl
Journal:  Eur J Clin Invest       Date:  1979-12       Impact factor: 4.686

8.  Presence of type III collagen in guinea-pig dermal scar.

Authors:  M J Barnes; L F Morton; R C Bennett; A J Bailey; T J Sims
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

9.  Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease.

Authors:  E D Bateman; M Turner-Warwick; B C Adelmann-Grill
Journal:  Thorax       Date:  1981-09       Impact factor: 9.139

10.  Serum type III procollagen peptide: indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workers.

Authors:  I Okazaki; K Maruyama; Y Kobayashi; R Lilis; Y Suzuki
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

View more
  3 in total

1.  Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.

Authors:  R P Schins; R J Lamers; B Préat; P J Borm
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

2.  Respiratory effects and serum type III procollagen in potato sorters exposed to diatomaceous earth.

Authors:  T H Jorna; P J Borm; K D Koiter; J J Slangen; P T Henderson; E F Wouters
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

3.  Transpulmonary gradient of type III procollagen peptides: acute effects of cardio-pulmonary bypass.

Authors:  N K Harrison; G J Laurent; T W Evans
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.